In reviewHealthcare20 July 2026

Tempus AI, Inc. to acquire Personalis, Inc.

Verified deal facts, source-backed narrative, and the Exit Mode founder lens for SME readers preparing to sell.

Deal facts

Buyer
Tempus AI, Inc.
Target
Personalis, Inc.
Deal value
Not disclosed
Announced
20 July 2026
Status
In review
Sector
Healthcare
Country
United States
Consideration
Not stated
What we know

Tempus AI, Inc. has agreed to acquire Personalis, Inc. in a strategic acquisition within the healthcare sector. Both companies are based in the United States, and the transaction was announced on 20 July 2026. The specific financial terms of the deal, including the total value and the form of consideration, have not been disclosed. Consequently, no figures regarding the purchase price or currency are available for this transaction. The acquisition represents a move by Tempus AI to integrate Personalis into its existing operations, although the precise strategic rationale is not detailed in the available data. The deal remains in the review phase, with no completion date currently reported. As of the latest update, the transaction is subject to regulatory approval and other standard closing conditions. This summary reflects only the confirmed facts provided, without speculation on future outcomes or comparative market analysis. The status indicates that the process is ongoing, and stakeholders should await further official announcements regarding the finalisation of the agreement.

More M&A Tools

Explore the Toolkit

Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.

Access now

Deal timeline

1 update
  1. CMA invitation to comment

    Tempus AI, Inc. M&A filing involving Personalis, Inc.

    Item 8.01 Other Events. As previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation (“ Personalis ” or the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Tempus AI, Inc., a Nevada corporation (“ Tempus ” or “ Parent ”), Aviary Development, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (“ Merger Sub I

    Source

Explore

Browse adjacent archives

Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.

Similar deals

Similar deals

Other Healthcare M&A activity tracked by Exit Mode.

Buyer history

Tempus AI, Inc.

See every published Exit Mode archive entry where this buyer appears.

View buyer profile

Methodology

How this page is built

Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.

Back to the archive